Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Else Marie Agger

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cellsThomas Lindenstrøm, Else Marie Agger, Karen S Korsholm, et al.
Vaccine|July 5, 2011
Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomesIda Rosenkrands, Carina Vingsbo-Lundberg, Trine Junker Bundgaard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2017
Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective EfficacyRolf Billeskov, Yichuan Wang, Shahram Solaymani-Mohammadi, et al.
Tuberculosis (Edinburgh, Scotland)|March 8, 2006
Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosisJulia Vipond, Simon O Clark, Graham J Hatch, et al.
Frontiers in Immunology|January 31, 2018
High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against TuberculosisRolf Billeskov, Thomas Lindenstrøm, Joshua Woodworth, et al.
Plos One|August 16, 2016
Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of TuberculosisRolf Billeskov, Esterlina V Tan, Marjorie Cang, et al.
Plos One|June 2, 2017
The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among GreenlandersSascha Wilk Michelsen, Bolette Soborg, Lars Jorge Diaz, et al.
Plos One|December 19, 2013
ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccinationTruc Hoang, Claus Aagaard, Jes Dietrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2014
Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnosticsNiels Peter H Knudsen, Sara Nørskov-Lauritsen, Gregory M Dolganov, et al.
Plos One|November 11, 2008
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvantArun T Kamath, Anne-Françoise Rochat, Mario P Valenti, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cellsThomas Lindenstrøm, Else Marie Agger, Karen S Korsholm, et al.
Vaccine|July 5, 2011
Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomesIda Rosenkrands, Carina Vingsbo-Lundberg, Trine Junker Bundgaard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2017
Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective EfficacyRolf Billeskov, Yichuan Wang, Shahram Solaymani-Mohammadi, et al.
Tuberculosis (Edinburgh, Scotland)|March 8, 2006
Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosisJulia Vipond, Simon O Clark, Graham J Hatch, et al.
Frontiers in Immunology|January 31, 2018
High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against TuberculosisRolf Billeskov, Thomas Lindenstrøm, Joshua Woodworth, et al.
Plos One|August 16, 2016
Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of TuberculosisRolf Billeskov, Esterlina V Tan, Marjorie Cang, et al.
Plos One|June 2, 2017
The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among GreenlandersSascha Wilk Michelsen, Bolette Soborg, Lars Jorge Diaz, et al.
Plos One|December 19, 2013
ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccinationTruc Hoang, Claus Aagaard, Jes Dietrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2014
Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnosticsNiels Peter H Knudsen, Sara Nørskov-Lauritsen, Gregory M Dolganov, et al.
Plos One|November 11, 2008
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvantArun T Kamath, Anne-Françoise Rochat, Mario P Valenti, et al.
Pageof 9